1681 — Consun Pharmaceutical Balance Sheet
0.000.00%
Last trade - 00:00
- HK$5.03bn
- HK$1.97bn
- CNY2.59bn
- 98
- 87
- 75
- 99
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,383 | 1,940 | 2,426 | 3,039 | 3,583 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 792 | 458 | 370 | 296 | 310 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,410 | 2,659 | 3,056 | 3,623 | 4,278 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 661 | 676 | 725 | 746 | 739 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 3,708 | 3,950 | 4,363 | 4,892 | 5,508 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,296 | 1,332 | 1,357 | 1,350 | 1,495 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,714 | 1,730 | 1,745 | 1,747 | 1,881 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 1,994 | 2,220 | 2,618 | 3,145 | 3,627 |
Total Liabilities & Shareholders' Equity | 3,708 | 3,950 | 4,363 | 4,892 | 5,508 |
Total Common Shares Outstanding |